Skip to content

Multicenter Study on the Correction of Prolapse Via Laparoscopy

Multicenter Study on the Correction of Prolapse Via Laparoscopy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06815731
Enrollment
181
Registered
2025-02-07
Start date
2023-10-01
Completion date
2026-05-30
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Disorders

Brief summary

In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.

Detailed description

In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.

Interventions

PROCEDURESacropexy without posterior mesh fixation on the puborrectalis muscle

Sacropexy without posterior mesh fixation on the puborrectalis muscle

PROCEDURElateral laparoscopic suspension (LLS)

lateral laparoscopic suspension (LLS)

Sponsors

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with Stage II- IV primary or recurrent prolapse affecting the anterior or middle vaginal compartment with or without minimal posterior defect (Stage I) according to the POP-Q.

Exclusion criteria

* History of abdominal prolapse reconstructive surgery. * History of prolapse reconstructive surgery with vaginal meshes. * Stage I according to the POP-Q classification or asymptomatic prolapse. * Medical contraindication for general anaesthesia. * Patient preference for vaginal surgical treatment. * Patient does not wish to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Pelvic Organ Prolapse Distress Inventoryup to 12 monthsPelvic Organ Prolapse Distress Inventory (POPDI-6) Scores range between 0 and 24 for the POPDI-6
Colorectal-Anal Distress Inventoryup to 12 monthsColorectal-Anal Distress Inventory (CRADI-8) Scores between 0 and 32 for the CRADI-8
Urinary Distress Inventoryup to 12 monthsUrinary Distress Inventory (UDI-6) Scores between 0 and 24 for the UDI-6.
Number of patients with symptomatic failureup to 12 monthsNumber of patients with symptomatic failure , defined as a positive response (accompanied by any degree of discomfort) to the following question on the validated questionnaire regarding prolapse symptoms (PFDI-20): Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?

Secondary

MeasureTime frameDescription
Intestinal and pain symptomsup to 12 monthsSubjective or functional success is defined as an improvement of ≥15 points per domain (the minimally important difference) or a decrease in the total score of 45 points (the minimally important difference). The PISQ-2 questionnaire has a score range between 0 and 48, and a difference ≥ 6 points is considered a minimally important difference.
Anatomical resultup to 12 monthsAnatomical results are defined as any POP-Q measurement below the hymen. Anatomical variables of prolapse: POPQ classification : * Anterior compartment: Aa, Ba * Middle compartment: C or D * Posterior compartment: Ap, Bp

Countries

Spain

Contacts

Primary ContactMaría Luisa Sánchez Ferrer, MD
marisasanchezferrer1@gmail.com968369500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026